comparemela.com

Latest Breaking News On - Revolution medicines inc - Page 11 : comparemela.com

Cyclo Therapeutics (NASDAQ:CYTH) and Revolution Medicines (NASDAQ:RVMD) Critical Review

Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) and Revolution Medicines (NASDAQ:RVMD – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership. Profitability This table compares Cyclo Therapeutics and Revolution […]

Revolution Medicines, Inc (NASDAQ:RVMD) Receives Consensus Rating of Buy from Brokerages

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has received an average rating of “Buy” from the ten ratings firms that are presently covering the company, Marketbeat reports. Ten equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have issued ratings on the stock in […]

Revolution Medicines (NASDAQ:RVMD) Price Target Increased to $42 00 by Analysts at Wedbush

Revolution Medicines (NASDAQ:RVMD) Price Target Increased to $42 00 by Analysts at Wedbush
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Enzon Pharmaceuticals (OTCMKTS:ENZN) and Revolution Medicines (NASDAQ:RVMD) Financial Review

Enzon Pharmaceuticals (OTCMKTS:ENZN – Get Free Report) and Revolution Medicines (NASDAQ:RVMD – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership. Analyst Ratings This is a breakdown of current […]

Revolution Medicines (NASDAQ:RVMD) Announces Earnings Results, Misses Estimates By $0 29 EPS

Revolution Medicines (NASDAQ:RVMD – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($1.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.85) by ($0.29), Briefing.com reports. Revolution Medicines had a negative net margin of 1,003.36% and a negative return on equity of 38.92%. The firm had revenue of $0.74 […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.